Perry Stambolsky, Ph.D.
Affiliations: | 2008 | MCB Molecular Cell Biology | Weizmann Institute of Science, Rehovot, Israel |
Area:
Molecular BiologyGoogle:
"Perry Stambolsky"Parents
Sign in to add mentor| Varda Rotter | grad student | 2008 | Weizmann Institute | |
| (The opposing roles of wt p53 and mutant p53 in the regulation of cell death.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Weisz L, Zalcenstein A, Stambolsky P, et al. (2019) Retraction: Transactivation of the Gene Contributes to Mutant p53 Gain of Function. Cancer Research. 79: 2085 |
| Kalo E, Kogan-Sakin I, Solomon H, et al. (2012) Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species. Journal of Cell Science. 125: 5578-86 |
| Dell'Orso S, Fontemaggi G, Stambolsky P, et al. (2011) ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. Omics : a Journal of Integrative Biology. 15: 305-12 |
| Madar S, Stambolsky P, Rotter V. (2011) Unleash the wild type: restoration of p53 suppressive activity in skin cancer. Cell Cycle (Georgetown, Tex.). 10: 736-7 |
| Kogan-Sakin I, Tabach Y, Buganim Y, et al. (2011) Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. Cell Death and Differentiation. 18: 271-81 |
| Stambolsky P, Tabach Y, Fontemaggi G, et al. (2010) Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell. 17: 273-85 |
| Stambolsky P, Tabach Y, Fontemaggi G, et al. (2010) Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53 (DOI:10.1016/j.ccr.2009.11.025) Cancer Cell. 17: 523 |
| Zemach A, Paul LK, Stambolsky P, et al. (2009) The C-terminal domain of the Arabidopsis AtMBD7 protein confers strong chromatin binding activity. Experimental Cell Research. 315: 3554-62 |
| Kalo E, Buganim Y, Shapira KE, et al. (2007) Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Molecular and Cellular Biology. 27: 8228-42 |
| Buganim Y, Kalo E, Brosh R, et al. (2006) Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction. Cancer Research. 66: 10750-9 |